 |
PDBsum entry 2vwc
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Med Chem
51:2853-2857
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular characterization of macbecin as an Hsp90 inhibitor.
|
|
C.J.Martin,
S.Gaisser,
I.R.Challis,
I.Carletti,
B.Wilkinson,
M.Gregory,
C.Prodromou,
S.M.Roe,
L.H.Pearl,
S.M.Boyd,
M.Q.Zhang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Macbecin compares favorably to geldanamycin as an Hsp90 inhibitor, being more
soluble, stable, more potently inhibiting ATPase activity (IC50 = 2 microM) and
binding with higher affinity (Kd = 0.24 microM). Structural studies reveal
significant differences in their Hsp90 binding characteristics, and
macbecin-induced tumor cell growth inhibition is accompanied by characteristic
degradation of Hsp90 client proteins. Macbecin significantly reduced tumor
growth rates (minimum T/C: 32%) in a DU145 murine xenograft. Macbecin thus
represents an attractive lead for further optimization.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Vozzolo,
B.Loh,
P.J.Gane,
M.Tribak,
L.Zhou,
I.Anderson,
E.Nyakatura,
R.G.Jenner,
D.Selwood,
and
A.Fassati
(2010).
Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.
|
| |
J Biol Chem,
285,
39314-39328.
|
 |
|
|
|
|
 |
M.W.Amolins,
and
B.S.Blagg
(2009).
Natural product inhibitors of Hsp90: potential leads for drug discovery.
|
| |
Mini Rev Med Chem,
9,
140-152.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |